Michael T. Cullen
2020
In 2020, Michael T. Cullen earned a total compensation of $611.2K as Executive Chairman at Panbela Therapeutics, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,750 |
|---|---|
| Option Awards | $153,400 |
| Salary | $316,000 |
| Total | $611,150 |
Cullen received $316K in salary, accounting for 52% of the total pay in 2020.
Cullen also received $141.8K in non-equity incentive plan and $153.4K in option awards.
Rankings
In 2020, Michael T. Cullen's compensation ranked 10,448th out of 13,090 executives tracked by ExecPay. In other words, Cullen earned more than 20.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,448 out of 13,090 | 20th |
Division Manufacturing | 4,477 out of 5,620 | 20th |
Major group Chemicals And Allied Products | 1,860 out of 2,253 | 17th |
Industry group Drugs | 1,629 out of 1,953 | 17th |
Industry Pharmaceutical Preparations | 1,203 out of 1,458 | 18th |
Source: SEC filing on April 15, 2021.
Cullen's colleagues
We found two more compensation records of executives who worked with Michael T. Cullen at Panbela Therapeutics in 2020.